Security Snapshot

BlossomHill Therapeutics, Inc. - Common Stock, $0.0001 par value per share (BLSM) Institutional Ownership

CUSIP: 095130100

13F Institutional Holders and Ownership History for Q3 2026

13F reference period

Q3 2026

Institutions Reporting

26

Shares (Excl. Options)

14.1MFull value: 14,102,056 · shares · 30 Sep 2026

Price

$18.64

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+14,052,056
Value change
+$261,872,338
Number of holders
26
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
31,785,104
SEC-reported price per share
$14.40
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • BLSM - BlossomHill Therapeutics, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 095130100.
  • 26 institutions reported positions in Q3 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • The headline uses Q3 2026 reported holdings.
  • Quarter-over-quarter comparison is unavailable because the immediately preceding quarter is missing.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 26 institutions filings for Q3 2026.

Open SEC evidence

Security key

095130100

13F reference period

Q3 2026

13F holders

26

13D/G owners

6

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
BLSM
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cui Jingrong Jean 12% $57,213,187 3,973,138 Jingrong Jean Cui 30 Sep 2026
Cormorant Asset Management, LP 12% 3,615,362 Chen Bihua 06 Aug 2026
ORBIMED ADVISORS LLC 8.9% 2,714,279 ORBIMED ADVISORS LLC 10 Aug 2026
Janus Henderson Group Ltd. 7.8% $46,066,039 2,471,354 JANUS HENDERSON GROUP Ltd. 30 Sep 2026
PERCEPTIVE ADVISORS LLC 5.9% 1,808,533 Perceptive Advisors LLC 07 Aug 2026
Vivo Innovation Fund II Holdings, L.P. 4.7% -13% $27,843,314 -$3,495,000 1,493,740 -11% Vivo Innovation Fund II Holdings, L.P. 30 Sep 2026
As of 30 Sep 2026, 26 institutional investors reported holding
14.1MFull value: 14,102,056 · shares · 30 Sep 2026
shares of BlossomHill Therapeutics, Inc. - Common Stock, $0.0001 par value per share (BLSM). This represents 44% of the company’s total
31.79MFull value: 31,785,104 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 24 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
44%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Cormorant Asset Management, LP 11% 3,614,034 4.5% $67,365,594
ORBIMED ADVISORS LLC 8.5% 2,714,279 0.93% $50,594,161
PERCEPTIVE ADVISORS LLC 5.7% 1,812,193 0.63% $33,779,278
Vivo Capital, LLC 4.7% 1,493,740 3.1% $27,843,314
DEERFIELD MANAGEMENT COMPANY, L.P. 4.5% 1,446,000 0.42% $26,953,440
Janus Henderson Group Ltd. 4.2% 1,336,993 0.01% $24,861,385
VANGUARD CAPITAL MANAGEMENT LLC 1.4% 433,302 0% $8,076,749
NEXTBio Capital Management LP 0.79% 250,000 2% $4,660,000
SILVERARC CAPITAL MANAGEMENT, LLC 0.64% 202,104 0.46% $3,767,219
Opaleye Management Inc. 0.55% 175,000 0.37% $3,262,000
a16z Capital Management, L.L.C. 0.39% 125,000 0.01% $2,330,000
GEODE CAPITAL MANAGEMENT, LLC 0.37% 119,176 0% $2,222,828
Monashee Investment Management LLC 0.25% 80,000 4.5% $1,491,200
VANGUARD FIDUCIARY TRUST CO 0.19% 60,281 0% $1,123,638
Birchview Capital, LP 0.16% 50,000 0.54% $932,000
Ghisallo Capital Management LLC 0.16% 50,000 0.02% $932,000
GOLDMAN SACHS GROUP INC 0.1% 30,805 0% $574,205
STATE STREET CORP 0.05% 17,200 0% $320,608
VANGUARD PORTFOLIO MANAGEMENT LLC 0.03% 10,932 0% $203,772
Jump Financial, LLC 0.03% 10,223 0% $190,557
TWO SIGMA INVESTMENTS, LP 0.03% 10,100 0% $188,264
Aster Capital Management (DIFC) Ltd 0.02% 4,822 0.03% $89,882
Vanguard Global Advisers, LLC 0.01% 3,765 0% $70,180
Legal & General Group Plc 0.01% 1,612 0% $30,836

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
1
Headline period
Q3 2026
Rows shown
1-1 of 1
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 14,102,056 $262,804,338 +$261,872,338 $18.64 26
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .